Health & Wellness Today New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.

Press releases published on June 3, 2026

Jun. 3, 2026

RadNet Announces a Proposed $200 Million Incremental Term Loan to Fund Strategic Growth Opportunities

Indeterminate GlobeNewswire

Jun. 3, 2026

Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million

Indeterminate GlobeNewswire

Jun. 3, 2026

Biogen Announces Upcoming Kidney Presentations at European Renal Association and American Transplant Congresses

Indeterminate GlobeNewswire

Jun. 3, 2026

Dyne Therapeutics Announces Completion of Enrollment in Registrational Expansion Cohort of ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1 (DM1)

Indeterminate GlobeNewswire

Jun. 3, 2026

TG Therapeutics Announces Positive Results from Phase 1 Trial Evaluating Subcutaneous BRIUMVI® (ublituximab-xiiy)

Indeterminate GlobeNewswire

Jun. 3, 2026

Palvella Therapeutics Announces Completion of FDA Pre-NDA Meeting for QTORIN™ Rapamycin in Microcystic Lymphatic Malformations

Indeterminate GlobeNewswire

Jun. 3, 2026

Celcuity Inc. Announces Public Offering of Convertible Senior Notes Due 2032

Indeterminate GlobeNewswire

Jun. 3, 2026

Mammogen Secures Up to $30 Million Series A Financing Backed by Leading U.S. Public Retirement System to Advance Blood-Based RNA Breast Cancer Detection Platform

Indeterminate GlobeNewswire

Jun. 3, 2026

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 3, 2026

SweetWater Brewing Unveils Atlanta-Wide Soccer Celebration as Global Fans Descend on the City This Summer

Indeterminate GlobeNewswire

Jun. 3, 2026

Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors

Indeterminate GlobeNewswire

Jun. 3, 2026

Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress

Indeterminate GlobeNewswire

Jun. 3, 2026

Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer

Indeterminate GlobeNewswire

Jun. 3, 2026

FibroBiologics Announces First Patients Dosed in Phase 1/2 Clinical Trial Evaluating CYWC628 for the Treatment of Diabetic Foot Ulcers

Indeterminate GlobeNewswire

Jun. 3, 2026

Avalyn Reports First Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

Jun. 3, 2026

Tenaya Therapeutics Announces Interim Data from MyPEAK™-1 Showing Treatment of MYBPC3-associated HCM with TN-201 Gene Therapy Resulted in Consistent Signs of Cardiac Remodeling and Reductions in Symptoms

Indeterminate GlobeNewswire

Jun. 3, 2026

Dark Horse Consulting Group and Altruist Biologics Announce Memorandum of Understanding to Advance Biologics Manufacturing and Development in China

Indeterminate GlobeNewswire

Jun. 3, 2026

Axsome Therapeutics Announces Settlement Resolving All SUNOSI® (solriamfetol) Patent Litigation

Indeterminate GlobeNewswire

Jun. 3, 2026

Upstream Bio to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Jun. 3, 2026

Medicenna’s MDNA11 Potential in Earlier Line Melanoma Setting Highlighted in Presentation of the NEO-CYT trial at ASCO 2026

Indeterminate GlobeNewswire